Cargando…

Autism with Epilepsy: A Neuropsychopharmacology Update

The association between autism spectrum disorders (ASD) and epilepsy has been extensively documented, and the estimated prevalence varies depending upon the selected population and the clinical characteristics. Currently, there are a lack of studies assessing the patient care pathways in ASD, partic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canitano, Roberto, Palumbi, Roberto, Scandurra, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601574/ https://www.ncbi.nlm.nih.gov/pubmed/36292706 http://dx.doi.org/10.3390/genes13101821

Ejemplares similares

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
por: Canitano, Roberto, et al.
Publicado: (2008)

Excitation/Inhibition Modulators in Autism Spectrum Disorder: Current Clinical Research
por: Canitano, Roberto, et al.
Publicado: (2021)

Editorial: Autism Spectrum Disorders: Developmental Trajectories, Neurobiological Basis, Treatment Update
por: Canitano, Roberto, et al.
Publicado: (2017)

Neuropsychopharmacological profiling of scoparone in mice
por: Kowalczyk, Joanna, et al.
Publicado: (2022)

Neurodevelopmental Disorders and Adaptive Functions: A Study of Children With Autism Spectrum Disorders (ASD) and/or Attention Deficit and Hyperactivity Disorder (ADHD)
por: Scandurra, Valeria, et al.
Publicado: (2019)

Editorial: Autism Spectrum Disorders: Developmental Trajectories, Neurobiological Basis, Treatment Update, Volume 2
por: Canitano, Roberto, et al.
Publicado: (2020)

New frontiers in the neuropsychopharmacology of mental illness
por: Renoir, Thibault
Publicado: (2014)

Neuropsychopharmacological effects of midazolam on the human brain
por: Wang, Junkai, et al.
Publicado: (2020)

Canadian College of Neuropsychopharmacology 2022 award winners
Publicado: (2022)

Exploring new frontiers in neuropsychopharmacology: SSRIs for stroke
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2011)

The neuropsychopharmacology of cannabis: A review of human imaging studies
por: Bloomfield, Michael A.P., et al.
Publicado: (2019)

New Experimental Treatments for Core Social Domain in Autism Spectrum Disorders
por: Canitano, Roberto
Publicado: (2014)

22q11 Deletion Syndrome and Multiple Complex Developmental Disorder: A Case Report
por: Scandurra, Valeria, et al.
Publicado: (2013)

New Treatment Perspectives in Autism Spectrum Disorders
por: Canitano, Roberto, et al.
Publicado: (2015)

Neuropsychopharmacology of Psychosis: Relation of Brain Signals, Cognition, and Chemistry
por: Schmidt, André, et al.
Publicado: (2014)

Utilizing resources of neuropsychopharmacology to address the opioid overdose crisis
por: Phillips, Anthony G., et al.
Publicado: (2018)

Japanese Society of Neuropsychopharmacology: “Guideline for Pharmacological Therapy of Schizophrenia”
Publicado: (2021)

Autism with co-occurring epilepsy care pathway in Europe
por: Mendez, Maria A., et al.
Publicado: (2023)

Autism Spectrum Disorders and Schizophrenia Spectrum Disorders: Excitation/Inhibition Imbalance and Developmental Trajectories
por: Canitano, Roberto, et al.
Publicado: (2017)

Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
por: Chávez-Castillo, Mervin, et al.
Publicado: (2019)

Identification of a Novel SHANK2 Pathogenic Variant in a Patient with a Neurodevelopmental Disorder
por: Doddato, Gabriella, et al.
Publicado: (2022)

Investigation of Neuropsychopharmacological Effects of a Polyherbal Formulation on the Learning and Memory Process in Rats
por: Shah, JS, et al.
Publicado: (2011)

The 43rd Annual Meeting of the Canadian College of Neuropsychopharmacology, November 4, 2021
Publicado: (2022)

Subtyping the Autism Spectrum Disorder: Comparison of Children with High Functioning Autism and Asperger Syndrome
por: de Giambattista, Concetta, et al.
Publicado: (2018)

Indian Rauwolfia research led to the evolution of neuropsychopharmacology & the 2000 Nobel Prize (Part I)
por: Tandon, Prakash N.
Publicado: (2021)

Indian Rauwolfia research led to the evolution of neuropsychopharmacology & the 2000 Nobel Prize (Part II)
por: Tandon, Prakash N.
Publicado: (2021)

Integrating Patients’ Expectations into the Management of Their Depression: Report of a Symposium at the European College of Neuropsychopharmacology Congress
por: Demyttenaere, Koen, et al.
Publicado: (2019)

Autism Spectrum Disorder and Duchenne Muscular Dystrophy: A Clinical Case on the Potential Role of the Dystrophin in Autism Neurobiology
por: Simone, Marta, et al.
Publicado: (2021)

Neuropsychopharmacology reviews 2022 hot topics: the prenatal environment and risk for mental illness in young people
por: Roffman, Joshua L., et al.
Publicado: (2021)

Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers
por: Leoncini, Silvia, et al.
Publicado: (2022)

Neuropsychopharmacology of Emerging Drugs of Abuse: meta- and para-Halogen-Ring-Substituted α-PVP (“flakka”) Derivatives
por: Nadal-Gratacós, Núria, et al.
Publicado: (2022)

Advancing equity, diversity, and inclusion in the American College of Neuropsychopharmacology (ACNP): advances, challenges, and opportunities to accelerate progress
por: Henningfield, Jack E., et al.
Publicado: (2020)

A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder
por: Craig, Francesco, et al.
Publicado: (2016)

Sex-Gender Comparisons in Comorbidities of Children and Adolescents With High-Functioning Autism Spectrum Disorder
por: Margari, Lucia, et al.
Publicado: (2019)

Neuropsychopharmacology (NPP) 2020 report on gender balance among corresponding authors and reviewers: before and during the COVID-19 pandemic
por: Hupalo, Sofiya, et al.
Publicado: (2022)

Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology: Clinical practice guideline for social anxiety disorder (2021)
por: Asakura, Satoshi, et al.
Publicado: (2023)

Editorial: Metabolic profiles of autistic and typically developing children
por: Palumbi, Roberto
Publicado: (2022)

Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms
por: Takeuchi, Hiroyoshi, et al.
Publicado: (2021)

Clinical neurophysiology in childhood headache
por: Canitano, Roberto, et al.
Publicado: (2004)

Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental
por: Bennabi, D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5vbbu7a7kugh53bo7a87dd1qep